Hypokalemia and its Correlates among Nigerian SARS-CoV-2 Infected Patients https://doi.org/10.60787/NMJ-64-1-225

Main Article Content

Amadi Collins
Lawson Stephenson
Bright Amadi

Keywords

Hypokalemia, Serum Potassium, SARS-CoV-2, Correlates

Abstract

Background: Disorders of plasma potassium are common among patients of western populations with SARS-CoV-2 infection which reportedly underlies worse clinical outcomes of the disease. Hence, the current study evaluated the pattern of potassium disorders and their clinical correlates among Nigerians with SARS-CoV-2 infection.


Methodology: Retrospective data of eligible adult patients managed at the Eleme COVID-19 treatment center in Port Harcourt during the 2020-2022 period following a positive real-time RT-PCR test from a nasopharyngeal swab were enrolled for this study. Baseline data were retrieved from medical files/notes by research assistants using extraction templates and analyzed accordingly.


Results: Hypokalemia was recorded in 323(62.8%) subjects out of 515 eligible subjects. Mild, moderate, and severe hypokalemia was recorded among 32(9.9%), 219(67.9%), and 72(22.2%) subjects, respectively. Subjects with severe hypokalemia had higher systolic blood pressure (SBP), CRP, D-dimer, and neutrophil count, but lower albumin levels, lymphocyte, and platelet counts compared to those with mild-moderate hypokalemia (p<0.05). Inverse relationships existed between potassium and SBP, sodium, CRP, D-dimer, and neutrophil count while a positive relationship existed with albumin, lymphocyte counts, platelet counts, and oxygen saturation among subjects with hypokalemia (p<0.05). Compared to those with mild-moderate hypokalemia, those with severe hypokalemia were associated with severe SARS-CoV-2 infection (OR: 5.671; [95%CI:4.467-7.365]; p<0.001) and unfavorable clinical outcomes (OR:7.863; [95%CI:6.502-9.342]; p<0.001).


Conclusion: The findings suggest a high frequency of hypokalemia in association with severe infection and unfavorable clinical outcomes among studied subjects with SARS-CoV-2 infection. These findings should be considered during their clinical management. However, further studies are recommended to verify the conclusions of this study.

Abstract 220 | AbstractAGCNMJ64No1Page122 Downloads 128